<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 338 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page337.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=338">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 338 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 338</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=338"><img src="../thumb/338.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Endocrine System - 19.5 / 19.6 / 19.6.1                                        2020-04 / 301
       est., intrathec. /subconjunct.admin., sudd.cessat.of ther., high dos.  poss.with high dose hydrocortis. ther.beyond 48-72 hrs. & it may be   Contraindications: Known/suspect.prostat.Ca/ breast Ca.
       for prolong.treatm.           desir. to replace ther.with methylprednis.which caus. little/no Na   Side effects: Freq: Incr.haematocrit, incr.RBC count & Hb, mood
       Side effects: Oed., hypertens., incr.K excret.with poss. hypokalaem.  retent., monit.all pts.for evid.of intercurr. infect., prophylact.antacid   disords, amnes., headache, dizzin., paraesthes., hyperaesthes., hy-
       alkalos., card.fail.poss.induc., excess. metabol.effs.with poss.oste-  admin. recomm. in long term.ther., upper GI X-ray & ulc. regim. de-  pertens., diarrh., alopec., urticar., skin reacts., erythema, acne, dry
       oporos./ spontan. fract., nitrog.deplet.& hyperglycaem.with accen-  sir.in ulc.pts.complain.of gastr.distress, pt. supervis.aft.ther.cessat.  skin, skin irrit., prostat.disords., gynaecomast., mastodyn., applicat.
       tuat./precipit.of diabet.state, incr.appet., delay. wound heal., incr.  site react. Less freq: Hypersens.reacts., nervousn., depress., hos-
       infect.suscept., may mask infect., ac.adren.insuff., growth retardat.  SOLU-MEDROL, Pfizer [N/P/S in C]  tility, anx., irritabil, sleep apnoea, asthma, jaund., seborrh., balding,
       in childr., typic. adren.cortex hyperactiv.sympt.somet.lead.to fully de-  Methylprednisolone Na-succinate equiv.to methylprednisolone.  prurit., musc.cramps, myalg., urin.obstruct., libido changes, incr.
       velop.Cushing syndr., amenorrh., hyperhidros., skin thin., ocul.chang.,   Indications: Adrenocortic.insuffic., ac.rheumat. cardit, collagen dis.,   freq.of erects., interrupt./reduc.spermatogenes., priapism, prostat.
       ment.& neurolog. disturbs., IC hypertens esp.childr., ac. pancreatit.,   steroid respons.dermat. disords., allerg.states, ulcerat.colit., second.   abnormal./Ca, oligosperm., water retent., oed., LFT abnormalit., elec-
       asept.bone necros., incr.bld.coagulabil. with poss.thrombo-embol.  thrombocytopen., idiopath.thrombocytopen. purpura, cerebr.oed.,   trol.changes, weight gain, arter. vasodilat., naus. Freq:unknown:
       complicat., pept.ulc., musc. weakn./wast.  shock, organ transplantat., leukaemias & lymphomas, adjunct ther.  Hepat. neoplasms.
       Special precautions: Poss.tox.effs.from withdr./ cont. use/large   for N/V assoc. with Ca therapy, ac.spin.cord injury.  Warnings and special precautions: Only for use in men, not
       dos., extr.caution in CHF, hypertens., diab.mellit., epilep., glauc.,   (S4) INJ D/21.5.1/135, 136, L/21.5.1/25, 26.  for use in childr., only use if hypogonad. demonstrat. & excl.other
       ocul.H. simplex, infect.dis., chron.ren.fail., uraem., elderly, incr.   765082-004: 40 mg/ml, 1x Act-o-vial, R29,12  aetiology respons. for sympts.bef.init.treatm., not for age-relat. hy-
       insulin requirem., poss.mask.infect.sympt., avoid contact with   765104-008: 125 mg/2 ml, 1x Act-o-vial, R59,17  pogonad., bef.init.ensure diagnos.of lab. hypogonad.confirmat.&
       chickenpox/H zoster, reg.monit. dur. long course esp.hypertens./  765066-009: 500 mg/8 ml, 1x vial, R236,69  verify ser.testoster.conc. of at least 2 separ.morn., all testoster.
       glycosur./ hypokalaem. /GI discomf./ment.chang/fluid retent., poss.  765155-001: 1 g/16 ml, 1x vial, R473,38  meas.to be carried out in same lab., inform pts.of potent.incr.
                +
       reduc.Na intake & K  supplem., emerg. treatm.of infects., rapid IV   Dosage: Adjunct.ther.in life-threat.condits: 30 mg/kg IV over   CV risk, excl.risk of pre-exist.prostat.Ca prior to init.treatm., reg.
       inj.may cause CV collapse.    at least 30 mins, may be rep. every 4-6 hrs up to 48 hrs. Admin.  monitor.of prostate gland & breast recommend. in accord.with/
       Drug interactions: Barbits./carbamazepine/ phenytoin /primidone/  separate from other drugs. Eith. IV push through IV medic.chamb/   recomm.methods (min. 1x/yr. & 2x/yr.elderly/risk pts.)., progress.
       rifampic.may reduc.eff., excess. K loss with K-deplet.diuret., incr.  IV “piggy-back”sol.  of sub-clinic. prostat.Ca/benign prostat.hyperplas. poss. accel-
                      +
       GI effs. with NSAID’s, reduc./enhanc.respons.to anticoags., anti-  SLE: 1 g/day x3 day IV.  erat., avoid use in Ca pts at risk of hypercalcaem.& assoc.hy-
       diab./antihypertens.requirm.poss. incr., salicyl.ser.conc.poss.decr.,   MS: 1 g/day x3 days IV or 1 g/day IV for 5 days.  percalciur.due to bone metastases & monit.ser.calcium.reg., MI/
       antimuscarin.eff. poss. decr.in myasth.grav.  Oed.states: 30 mg/kg every other day x4 days IV or 1 g/day for 3,5   card.-hepat.- or ren.insuffic/hypertens./epilep/migraine hist &
                                     or 7 days IV. Admin.over at least 30 mins,& may be rept.if improvem.
       PRELONE, AI Pharm Ltd [N/P/S in C]  has not occur. within a wk.aft.ther.or as pt.condit.dictat.  discont.on deteriorat./dis.re-occurr., avoid use in ischaem.heart
                                                                  disease, monit.testoster.lev. at baseline & reg.interv.dur.treatm.,
       Prednisolone.                 Adjunct.for the prevent.of N&V assoc.with Ca chemotherapy:   indiv.dos.to ensure maint.of eugonadal testoster.lev., monit. Hb/
       Indications: Steroid respons.inflammat.condits.  Mild to mod.emetogenic ther: 250 mg IV over at least 5 min, 1 hr.  haematocrit/liv.funct./lipid profile reg., incr. sleep apnoea risk in
       (S4) SYRUP, [N/P/S in C] 28/21.5.1/0158  bef.chemother. at initiat.of chemother.& at discharge.  hypogonad.pts.treat.with testoster.esters esp.with risk facts.incl.
       805149-023: 15 mg/5 ml, 50 ml, R115,66  Sev.emetogen.chemother: 250 mg IV over at least 5 min. with me-  obesity/ chron. resp.dis., poss.improv.insulin sensitiv.in pts. achiev.
       805149-031: 15 mg/5 ml, 100 ml, R231,31  toclopramide or a butyrophenone 1 hr.bef.chemother., then 250 mg   norm.testoster.conc.follow.ther., irritabil./, nervousn./ weight gain
       Dosage: Indiv.accord.to dis., its sever.& pt. respons. Usual dos.  IV at init.of chemother. & at discharge.  & prolong or freq.erect. may indic.excess.expos. requir.dos.ad-
       range: 5-60 mg dly.in div.dos. Init.dos.to be maint./adjust.unt.satis-  Other indicat: 10-500 mg depend.on sev.of disord. Init.up to 250 mg   justm., athletes to be made aware of anti-doping test risk, not for
       fact. respons. observ.Total dly.dos.may be admin.once early morn.   IV over at least 5 mins., if great.than 250 mg, admin.over at least   use by women due to potent.virilising effs, avoid in pts with maj.
       / as double dos.on altern.days. Max.dos: 1 -2 mg/kg.  30 min. Subseq. dos.may be giv. IV/IM at interv.dictat.by pt. respon.   risk of non-compliance with safety instructs. (e.g. sev.alcohol.,
       (S4) TABS, [N/P/S in C] G3055  /clin.condit., Childr.& infts: accord.to condit.& respons.but not less   drug abuse, sev. psych.disords), testoster.can be transferr.to other
       Indications: Sev./ac.rheumat./dermatologic.& allerg.condits., col-  than 0,5 mg/kg every 24 hrs.  persons by close skin-to-skin cont.result.in incr. testoster. ser.lev.&
       lagen dis., musc-skelet.condits., foot disords.  Ac.spin.cord.injury: IV: 30 mg/kg bm in a bolus dose over 15   adverse effs., to avoid tfd.cover applicat.sites with cloth.once dry
       703720-002: 5 mg, 200, R301,91  mins, follow.by 45 min.pause, then contin.infus.of 5,4 mg/kg/hr for   and shower bef.any foreseen skin contact., not indicat. in pregn./
       Dosage: 2-20 tabs dly.in div.dos.  23 hrs, then stop abruptly. Treatm.should begin within 8 hrs.of injury.  lactat., pregn.women & childr.to avoid any contact with pt.applic.
       Contraindications: Pept.ulcerat., osteoporos., psychos., sev.psy-  Contraindications: Syst.fung.infects., ac. psychos., pept.ulc.,   sites., not indicat.for male sterility/impot., monit.prothromb.time
       choneuros., ac.vir./bact.infects., eye ulcerat., herpes zoster/simplex,   osteoporos.  INR with concom.anticoag.
       live vaccine vaccinat., pregn., lactat., syst.fung. infects.   Side effects: Fluid & electrol.disturbs., steroid myopathy., musc.  Interactions: Incr.eff.of oral anticoag., incr.oed. developm. risk
       Side effects: Electrol.disturbs., CF poss.induc., excess.metab.eff.  weakn., osteoporos., pathol./ spontan. fract., vertebr.compress.fract.,   with ACTH/corticoster.
       incl.osteoporos./hyperglycaem., incr.appet., delay.wound heal.,   aseptic necros., GI disturbs., imp.wound heal., petechiae, ecchymos.,
       incr.infects., pept. ulcerat.with poss.haemorrh./perforat., incr.in-  thin fragile skin, purpura, allerg. reacts., facial erythema, thinn.of   DEPO-TESTOSTERONE, Pfizer
       fect. suscept., ac.adren.insuffic., sympts.typic.of adren. cortex hy-  hair & scalp, subcut. & cutan.atrophy, post-inj.flare, sterile abscess   Testosterone cypionate.
       peractiv., Cushing’s syndr, amenorrh., ment.& neurolog.disturbs., IC   at inj.site, hyper/hypopigmentat., striae, acne, negat.nitrogen bal.,   Indications: Male: Eunuch., eunuchoid.defic. aft.castrat., climac-
       hypertens., thrombo-embol.complicat., may mask signs of infect.,   thromboembol. complicat., incr.IC-press., pseudotumour cerebri,   teric.sympts.second.to androg. defic., oligosperm.
       growth retardat.in childr., hyperhidros., ac. pancreatit., asept.bone   psych. derangem., seiz., insomn., nervousn., vertigo, sweat., menstr.  Male or female: Postmenopaus./senile osteoporos.as adjunct.ther.
       necros., musc.weakn.          irregul., Cushingoid state, suppress. of pituit.adren.axis, decr.carbo-  (S5) IM INJ. G2989. 100 mg/ml.
       Special precautions: Incr.insul.requirem.of diabet., CCF, infect.  hydr.tol., manifestat. of diab.mellit., incr.insul.or oral hypoglycaem.   718548-019: 10 ml, R433,18
       dis., chron.ren.fail., uraem., elderly, act./quiesc.TB, anaesthes./surg./  requirem., growth suppress.in childr., relat.adrenocortic.insuffic.,   Dosage: IMI use only.
       trauma, hypertens., reg.exam.advis.dur.longt.ther., discont. grad.  cataracts, incr. IOP, exophthalmos, latent infects.becom.active, op-  Eunuchism/eunuchoidism: 200-400 mg IM 3-4 wkly. Begin with
       Drug interactions: Barbits./phenylbutazone/ phenytoin/ri-  portunist. infects., suppress.react.to skin tests, anaphylact. reacts.  full therapeut. dos., adjust later to indiv.req.
       fampicin reduc.eff., reduc.respons.to anticoag., excess. K loss.  with/-out circulat.collapse, card. arrest, bronchosp., card.arrhythm.,   Male climacteric: 200-400 mg every 3-4 wks.
       with K-deplet.diuret.         bradycard., exist.emot./psychot.tend.poss. aggravat.  Oligospermia: To stimul.spermatogenes.when trial androg.ther.
       SOLU-CORTEF, Pfizer. [N/P/S in C]  Warnings and special precautions: May mask infects., grad.   indicat. 100-200 mg IM 3-6 wkly. for developm.& maint.of testi-
                                                                  cul.funct. Suppress. poss.foll.by rebound spermatogenes:
       Hydrocortisone Na succin.as hydrocortisone  withdr., stress, imp.wound heal., diabet., myasth.grav., monit.child   200 mg wkly x6-10 wks.
       Indications: Ac.adren.insuff., sev.shock, ac. hypersens.reacts, bi-  growth, TB, ocul. H.simplex, ulc.colit., diverticulit., fresh intest. anas-  Osteoporos: Adjust.accord.age, sex & indiv. condit. 200-400 mg IM
       lat.adrenolect., overwhelm. infects. with sev.toxic., SLE in relapse,   tomos., ulc., ren.insuff., hypertens., osteoporos., card.arrhythm., rou-  3-4 wkly.with adeq.diet & avoid prolong.immobilizat.
       aspirat. pneumonit.           tine lab.stud.incl. urinalys./ 2 hr.postprand.bld.sug./determinat.of BP   Contra-indications: Male breast Ca., known/ suspect.prostate
       (S4) INJ. G2957, G/21.5/201.  & BM, chest X-ray to be tak.at reg.interv.dur. prolong. ther., upper GI   Ca., card./hepat./ren. decompensat., hypercalcaem., imp.liv.funct.,
       709866-001: 100 mg/2 ml, 5x2 ml vials, R242,96  X-ray desir.in pts.with ulc. hist./ signif.dyspeps., cross.placent.barr.,   prepubert.males., pregn.
       765074-001: 100 mg/2 ml, 1x2 ml Act-o-vial, R33,48  excret.in breast milk, observ.infts.born to moth.receiv. substant. cor-  Side-effects: Priapism., hypercalcaem., female virilisat., voice
       765074-028: 100 mg/2 ml, 5x2 ml Act-o-vials, R167,40  ticoster.dos.for signs of adren. insuffic., immunisat., convuls.poss.  changes, oed., oligiosperm./reduc. ejacul.vol.aft. prolong admin./
       765120-003: 500 mg/4 ml, 1x4 ml Act-o-vial, R175,59  with concom. cyclosporin.  excess.dos., hypersens., gynaecomast., acne, skin reacts., loc.irrit.
       Dosage: Sev.shock: Init.ther.by IV admin.over one - sev.mins.   Drug interactions: Interacts.of known/likely clinic. signific.with   Special precautions: Breast Ca., do not admin. IVI., immobilis.
       Curr.medic.pract.tend to use high dos. of corticoster. Ref.to PI for   antibiot./antifung./ anticholinesteras./ anticoag./anticonvuls./   pts., organ.heart dis.
       sugg.dos.regimens.            antidiabet/ antihypertens./CV meds./diuret./ immuniz. agents/
       Cont. high dos.corticoster.ther.only until pt’s. condit. has stabilis.&   immunosuppress./neuromusc. block. agents/psycho-therapeut.   NEBIDO, Bayer
       usually not beyond 48 - 72 hrs.  agents/salicylat. & sympathomimet./analges. & antacids.  Testosterone undecanoate
       Other situat.in which adeq.prep.with IM cortisone/ hydro-  Indications: Testosterone replacem.in prim.& second. male hy-
       cortis.cannot be accomplish: Adults: Init.100-500 mg IV over   pogonad.
       at least 30 sec., dos.may be repeat.at interv.of 1, 3, 6 & 10 hrs. as   (S5) OILY SOL FOR INJ, A38/21.7/0641. 250 mg/ml
       indicat.by pt.respon.& clin.condit. Infts.& childr: Determ.by sev.of  19.6   Sex hormones   706461-001: 4 ml vial, R2 259,30
       condit.& pt. respons. but not less than 25 mg/day.     (see also oral contraception)  Dosage: Admin.by slow IMI only. Meas.ser. testosterone bef.init.
       Contraindications: H.simplex keratit., ac. psychos., TB, pept.ulc.,   treatm.&occas.at end of inj.interv.to determ.inj.interv.(to remain in
       Cushing syndr., fresh intest. anastomos, diverticulit., osteoporos., ren.   recomm. 10-14 wk range).
       insuffic., thromboembol.& psychot.tenden., diab. mellit., hypertens.,   19.6.1   Androgens and anabolic   1000 mg (1 vial) every 10-14 wks. 1  inj.interv. poss.reduc.to 6 wks.
                                                                                 st
       loc./system.infect., fung.dis., exanthemat. dis., pregn.partic.dur.first   Contraindications: Androg.depend.prostate/ male mammary
       trimest., deltoid musc.inj.,         steroids              gland Ca, hypercalcaem.accomp. malign.tumours, past/pres.liv.
       Side effects: Cushing syndr., adrenocort.insuff., prot., catabol.,   tumours, women.
       electrol.imbal., osteoporos., pept. ulc., mask.of infect., incr.BP, con-  Side effects: Diarrh., leg pain, arthralg., CNS effs., resp.disords.,
       vuls., skin reacts., petech. & purpura, menstr.irregul., insomn., psych.   ANDROGEL, Medi Challenge [P/S]  acne, breast/ testicul.pain, gynaecomast., prurit., skin disord., loc.
       disturbs., incr.IOP, poster.subcapsul. cataracts, incr. ICP, pancreat.,   Testosterone  reacts., polycythem., weight gain, musc.cramps, depress., sleep
       sweat., vertigo, weakn., myopathy, headache, exophthalmos., subcu-  Indications: Replacem.ther.for male hypogonad. when testoster.  apnoea, jaund., seborrh., bald., libido changes, revers.interupt./
       tan.& cutan. atrophy, post-inj flare., alter.gluc.metab. with aggravat.  defic.confirm.by clinic.signs & biochemic. tests.   reduc.spermatogenes.& testic. size with high dos., priapism, water
       of diab.mellit. incl.hyperglycaem.& glycosur., spontan.fracts., asept.  (S5) GEL, A40/21.7/0260. 50 mg/5 g  retent., hypersens. reacts.
       necros.of hip & humer., growth suppres.in childr., facial erythema,   3000765-001: 50 mg/5 g, 30 sachets, R591,66  Special precautions: Incr.prostat.hyperplas. developm. risk in el-
       ulcerat. oesophagit., anaphylax  Dosage: Observ.at least 6 hr.betw.applic.& bath./shower.  derly, excl.prostat.Ca, reg. prostat. examinat., monit.Hb & haemato-
       Warnings and special precautions: Grad. withdr., stress, imp.  Adults & elderly men: Apply 5 g by pt.to clean, dry, healthy skin of   crit, consid. different.diagnos.of hepat.tumour in pres. of sev. upper
       wound heal., diet.salt restrict., K-supplem., diab., myasth.grav.,   shoulders/ arms/abdom.once dly pref.in morn. Max: 10 g/day. Dose   abdom.pain/liv.enlargem./signs of intra-abdom. haemorrh., oed.pre-
       monit.child growth., if used dur.pregn.observ.newborn inft. closely for   may be incr./ reduc in relat.to ser.testosterone conc.meas. from 3   rd  disposit., no data on use in childr./adolesc.und.18 yrs., may potent.
       signs of hypoadrenal.& institute approp. ther. if pres., hypernatraem.  day aft.start.treatm. Adjust dos.in steps of 2,5 g of gel.  pre-exist. sleep apnoea, acquir./inherit.bld.clott. irreg.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page337.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page333.html">333</a>&nbsp;&nbsp;&nbsp;<a href="page334.html">334</a>&nbsp;&nbsp;&nbsp;<a href="page335.html">335</a>&nbsp;&nbsp;&nbsp;<a href="page336.html">336</a>&nbsp;&nbsp;&nbsp;<a href="page337.html">337</a>&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>&nbsp;&nbsp;&nbsp;<a href="page339.html">339</a>&nbsp;&nbsp;&nbsp;<a href="page340.html">340</a>&nbsp;&nbsp;&nbsp;<a href="page341.html">341</a>&nbsp;&nbsp;&nbsp;<a href="page342.html">342</a>&nbsp;&nbsp;&nbsp;<a href="page343.html">343</a>
             </td>
             <td width="35%"><a href="page339.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page339.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
